Jaskanwal D S Sara
Overview
Explore the profile of Jaskanwal D S Sara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
189
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sara J, Pillai J, Lerman L, Lerman A, Welker K
Int J Cardiol
. 2025 Feb;
424:133021.
PMID: 39894316
Introduction: Endothelial dysfunction represents the earliest detectable stage of atherosclerosis, is associated with an increased risk of cardiovascular events, and predicts cardiovascular disease (CVD) more effectively than traditional cardiovascular risk...
2.
Sara J, Rajai N, Breitinger S, Medina-Inojosa B, Lerman L, Lopez-Jimenez F, et al.
J Am Heart Assoc
. 2024 Nov;
13(21):e036812.
PMID: 39494599
Background: A subset of individuals with major depressive disorder (MDD) have a high burden of cardiovascular risk factors and cerebral small-vessel disease, implicating vascular disease in the development of depression....
3.
Sara J, Ahmad A, Toya T, Pardo L, Lerman L, Lerman A
J Am Heart Assoc
. 2021 Aug;
10(17):e021722.
PMID: 34459240
Background Anxiety disorders are the most prevalent mental disorders and are an emerging risk factor for coronary artery disease and its complications. We determine the relationship between having a clinical...
4.
Sara J, Singh P, Albright R
Int Urol Nephrol
. 2021 Jun;
54(3):713-714.
PMID: 34131857
No abstract available.
5.
Toya T, Corban M, Park J, Ahmad A, zcan I, Sebaali F, et al.
EuroIntervention
. 2020 Dec;
17(7):569-575.
PMID: 33342762
Background: Most studies dichotomise indices of coronary microvascular function to assess their prognostic values. Aims: We aimed to investigate whether coronary flow reserve (CFR) and hyperaemic microvascular resistance (HMR) as...
6.
Sara J, Toya T, Rihal C, Lerman L, Lerman A
Int J Cardiol
. 2020 Nov;
326:6-11.
PMID: 33152413
Clinical decision-making that best serves the interests of our patients requires the synthesis of evidence-based medicine, sound clinical judgment and guidelines. However, a relatively low percentage of clinical guidelines are...
7.
Sara J, Corban M, Prasad M, Prasad A, Gulati R, Lerman L, et al.
EuroIntervention
. 2019 Jan;
15(14):1262-1268.
PMID: 30636680
Aims: Myocardial bridging (MB), characterised by the epicardial coronary vessel diving into the myocardium, is present in up to one third of adults and is associated with angina and acute...
8.
Maor R, Sara J, Wanous A, Maor E, Pruthi S, Lerman A, et al.
Coron Artery Dis
. 2018 Nov;
29(8):687-693.
PMID: 30379695
Purpose: Data on long-term cardiovascular effects of aromatase inhibitors (AIs) are limited and conflicting. We sought to evaluate the effect of AIs on peripheral endothelial function in patients with breast...
9.
Sara J, Prasad M, Zhang M, Lennon R, Herrmann J, Lerman L, et al.
Am Heart J
. 2017 Aug;
190:1-11.
PMID: 28760202
Background: Coronary endothelial dysfunction (CED) is an early stage of atherosclerosis and is associated with adverse cardiovascular events. Inflammation may play a role in the development of endothelial dysfunction. To...
10.
Ning Y, Cheng Y, Liu L, Sara J, Cao Z, Zheng W, et al.
BMC Med
. 2017 Feb;
15(1):21.
PMID: 28148249
Background: Whether hypothyroidism is an independent risk factor for cardiovascular events is still disputed. We aimed to assess the association between hypothyroidism and risks of cardiovascular events and mortality. Methods:...